Travis et al identified risk factors associated with rebleeding after endoscopic therapy of non-variceal upper gastrointestinal bleeding. This can help to identify a patient who may require closer follow-up after endoscopy. The authors are from Brigham and Women's Hospital in Baston.
Patient selection: endoscopic therapy of non-variceal upper gastrointestinal hemorrhage
Parameters:
(1) liver disease
(2) bleeding source
(3) active bleeding seen at endoscopy
(4) therapy of bleeding source
(5) post-procedure heparin
(6) post-procedure proton pump inhibitor (PPI)
Parameter
Finding
Points
liver disease
none or mild
0
moderate or severe
1
bleeding source
ulcer
1
other
0
active bleeding seen at endoscopy
yes
1
no
0
therapy of bleeding source
epinephrine monotherapy
1
other
0
post-procedure heparin
yes
1
no
0
post-procedure PPI
no
1
yes
0
score =
= SUM(points for all 6 parameters)
Interpretation:
• minimum score: 0
• maximum score: 6
• The higher the score the greater the risk of rebleeding.
Score
Rebleeding Rate
0
7%
1
16%
2
37%
3
75%
4
100%
Performance:
• The area under the ROC curve was 0.69.
To read more or access our algorithms and calculators, please log in or register.
